Related Experiment Video
Updated: Mar 17, 2026

Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020
Spatially Resolved Opto-Omics Uncovers Functional Microglial Subtypes in Brain Metastasis
Ethan J Vallebuona1, Inna Smalley1
1The Department of Metabolism and Physiology, The Moffitt Cancer Center & Research Institute, Tampa, Florida.
Abstract:
The tumor microenvironment plays an important role in brain metastasis. To investigate microglial subtypes in the developing metastatic tumor microenvironment in this issue of Cancer Research, Tsuji and colleagues pioneer a cutting-edge approach for mapping the transcriptional fate of live, spatially identified cells using a method they call "opto-omics." Using a mouse model that enables microglia-specific transgenic expression of a photoconvertible fluorescent protein, the authors profile disease-associated microglia in spatial proximity to disseminated tumor cells (DTC) through intracerebral windows installed in the mouse skull. Microglia that spatially migrate to DTCs are photoconverted, and transcriptional profiling of these microglia reveals an overall enrichment in inflammatory gene programs with five distinct subpopulations corresponding to biological processes such as antigen presentation, type II IFN response, phagocytosis, TGFβ signaling, and tissue repair. This article describes a strategy to modulate the relative abundance of individual microglial subpopulations through pharmacologic perturbation of specific pathways, such as TGFβ, or through genetic ablation of "don't eat me" signals to reprogram protumor microglia. By developing opto-omics and demonstrating its functional integration with single-cell transcriptomics, the authors present a versatile platform for phenotypic profiling that may be applied in numerous areas of research. See related article by Tsuji et al., p. 1414.
Insights
Researchers developed opto-omics to map microglial subtypes in brain metastasis. This method reveals distinct microglial subpopulations and offers strategies to reprogram pro-tumor microglia for therapeutic potential.
Area of Science:
- Neuroscience
- Immunology
- Oncology
Background:
- The tumor microenvironment is critical in brain metastasis.
- Understanding microglial roles in this environment is essential for developing effective therapies.
Purpose of the Study:
- To investigate microglial subtypes within the developing brain metastatic tumor microenvironment.
- To pioneer a novel method for mapping the transcriptional fate of live, spatially identified cells.
Main Methods:
- Developed and utilized opto-omics, a cutting-edge approach combining photoconvertible fluorescent protein expression in microglia with spatial identification.
- Employed a mouse model with intracerebral windows to observe microglia in proximity to disseminated tumor cells (DTCs).
- Integrated opto-omics with single-cell transcriptomics for detailed transcriptional profiling.
Main Results:
- Identified five distinct microglial subpopulations associated with DTCs, enriched in inflammatory gene programs.
- These subpopulations correspond to biological processes including antigen presentation, type II interferon response, phagocytosis, TGFβ signaling, and tissue repair.
- Demonstrated strategies to modulate microglial subpopulation abundance via pharmacologic or genetic interventions.
Conclusions:
- Opto-omics provides a versatile platform for phenotypic profiling of live cells in vivo.
- The findings offer insights into microglial heterogeneity in brain metastasis and potential therapeutic targets.
- This approach can be applied to various research areas beyond brain metastasis.

